ResMed

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ResMed and other ETFs, options, and stocks.

About RMD

ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, chronic obstructive pulmonary disease, or COPD, and other chronic diseases. 

CEO
Michael J. Farrell
CEOMichael J. Farrell
Employees
10,600
Employees10,600
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
1989
Founded1989
Employees
10,600
Employees10,600

RMD Key Statistics

Market cap
38.26B
Market cap38.26B
Price-Earnings ratio
25.59
Price-Earnings ratio25.59
Dividend yield
0.87%
Dividend yield0.87%
Average volume
1.36M
Average volume1.36M
High today
$260.17
High today$260.17
Low today
$255.76
Low today$255.76
Open price
$257.66
Open price$257.66
Volume
820.56K
Volume820.56K
52 Week high
$293.81
52 Week high$293.81
52 Week low
$199.92
52 Week low$199.92

Stock Snapshot

With a market cap of 38.26B, ResMed(RMD) trades at $256.29. The stock has a price-to-earnings ratio of 25.59 and currently yields dividends of 87.3%.

During the trading session on 2026-02-19, ResMed(RMD) shares reached a daily high of $260.17 and a low of $255.76. At a current price of $256.29, the stock is +0.2% higher than the low and still -1.5% under the high.

Trading volume for ResMed(RMD) stock has reached 820.56K, versus its average volume of 1.36M.

The stock's 52-week range extends from a low of $199.92 to a high of $293.81.

The stock's 52-week range extends from a low of $199.92 to a high of $293.81.

RMD News

Simply Wall St 15h
A Look At ResMed Valuation After Robust Q2 Beat And Upgraded Analyst Outlook

ResMed (RMD) is back in focus after a strong fiscal Q2, where its Masks & Accessories and Devices businesses outperformed expectations and analysts responded by...

A Look At ResMed Valuation After Robust Q2 Beat And Upgraded Analyst Outlook
Simply Wall St 4d
Is ResMed’s Hardware-Led Margin Strength Quietly Redefining Its Software-Driven Narrative?

In the past few days, ResMed reported largely positive fiscal second-quarter 2026 results, with strength in its Masks & Accessories and Devices segments offsett...

Is ResMed’s Hardware-Led Margin Strength Quietly Redefining Its Software-Driven Narrative?

Analyst ratings

72%

of 29 ratings
Buy
72.4%
Hold
24.1%
Sell
3.4%

People also own

Based on the portfolios of people who own RMD. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.